Last reviewed · How we verify

NCT04941742

The Use of Fractionated Exhaled Nitric Oxide in the Diagnosis and Assessment of Disease Activity of Eosinophilic Esophagitis (Validation Phase)

Completed Last updated 10 May 2024
What this trial tests

trial in Eosinophilic Esophagitis in 71 participants. Completed in 22 December 2021.

Timeline
22 September 2020
Primary endpoint
22 December 2021
22 December 2021

Quick facts

Lead sponsorThe University of Texas Health Science Center, Houston
StatusCompleted
Study typeOBSERVATIONAL
Enrollment71
Start date22 September 2020
Primary completion22 December 2021
Estimated completion22 December 2021
Sites1 location across United States

Conditions studied

Sponsor

The University of Texas Health Science Center, Houston

Who can join

Adults 5 to 18, any sex, with Eosinophilic Esophagitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the relationship between fractionated exhaled nitric oxide, peripheral eosinophils, and plasma citrulline and ß-alanine in patients with eosinophilic esophagitis (EoE) compared to those without EoE. The hypothesis is that a combination of elevated fractional exhaled nitric oxide, increased peripheral eosinophils, and elevated plasma citrulline and ß-alanine is associated with active EoE.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Eosinophilic Esophagitis

Currently open trials in the same condition.

Other The University of Texas Health Science Center, Houston trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04941742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing